What is Adcetris (Brentuximab Vedotin) Adcetris (Brentuximab Vedotin) is the first approved CD-30 directed antibody drug conjugate
Drug Manufacturer / Marketeer :
M/S SEATTLE GENETICS, INC.
Indications: Adcetris® (Brentuximab Vedotin) injection for intravenous infusion is indicated for the treatment of:
- Hodgkins Lymphoma after failure of autologous stem cell transplant (ASCT)
- Hodgkins Lymphoma in patients who are not ASCT candidates after failure of at least 2 multiagent chemotherapy regimens
- Systemic anaplastic large cell lymphoma after failure of at least 1 multiagent chemotherapy regimen
Treatment: For treatment related information, please consult your treating Physician.
How supplied: Adcetris powder for infusion 50 mg vial
Storage and handling: Store at 2°- 8° C
How do we source the Drug?
SMIQ Pharma-India will assist in sourcing the drug through its efficient network, across the globe, and ensure the delivery is prompt. However, a valid prescription from the treating Oncologist is mandatory, with all relevant documents associated with its procurement is essential.
Company that Manufactures/ Markets: M/s Seattle Genetics, inc.
Assistance Cell in India: For ONCOLOGY DRUG: ADCETRIS (Brentuximab Vedotin) 50 mg price.
Contact us @ +91 7678048225 or by email firstname.lastname@example.org.